All conference sessions taking place at the Arizona Biltmore will be made available to watch on-demand in the IR Hub (a benefit of being a PCMA Member, Affiliate or Sponsor).
The registration desk will be open on Sunday, October 1 from 3:00 pm – 8:00 pm at the Arizona Biltmore in the conference center, McArthur Ballroom Foyer. If you are on property Sunday, we encourage you to check-in and pick up your name badge on Sunday to avoid lines on Monday morning.
Private meetings will only take place in person at the Arizona Biltmore.
| 7:00 am - 7:00 pm | Registration Open McArthur Ballroom Foyer | |
| 7:00 am - 6:00 pm | Private Meeting Rooms Open | |
| 7:30 am - 9:00 am | General Networking Breakfast McArthur Patio | |
| 7:30 am - 9:00 am | PCMA Diversity, Inclusion and Women’s Leadership Event & Networking Breakfast Gold Room
7:30 am – 8:15 am: Networking Breakfast Health Equity in Pharmaceutical Care Rebecca Lowell Edwards, Chief Communications Officer, Organon Michelle Gourdine, MD, Senior Vice President and Chief Medical Officer, CVS Caremark Moderator: Angie Yanez, Vice President, Industry Relations, Emisar | |
| 9:15 am - 12 pm | GENERAL SESSIONS McArthur Ballroom
9:15 am – 9:30 am Welcome from Conference Moderator Ian Spatz, National Advisor, Manatt Health
Opening Remarks from PCMA’s President & Chief Executive Officer JC Scott, President & Chief Executive Officer, PCMA
9:30 am – 9:45 am IRA Drug Pricing Provisions: Where are we today Ian Spatz, National Advisor, Manatt Health
9:45 am – 10:15 am IRA Drug Pricing Provisions: What’s ahead Claire Hutchinson, Assistant Vice President, Public Policy, Humana Ross Margulies, Partner, Foley Hoag Moderator: Ian Spatz, National Advisor, Manatt Health
10:15 am – 10:45 am Value Assessments in the Era of CMS Drug Price Negotiations Sarah Emond, President-Elect, Institute for Clinical and Economic Review (ICER) Moderator: Ian Spatz, National Advisor, Manatt Health View Details The legislation authorizing CMS to negotiate to prices of prescription drugs lays out the factors that CMS can consider in determining a Maximum Fair Price, and CMS has public guidance on how it is interpreting that legislative language. However, many questions remain on exactly what sources of information CMS will use, and how it will weigh the different sources of information in making its initial price offerings. In this session, hear how the results of value assessments may or may not be used CMS, and see the results of a special value assessment on two of the drugs that made the list of drugs to be negotiated next year.
10:45 am – 11:15 am Addressing Client Demands: Prescription drug affordability and access is key Jon Mahrt, President & Chief Operating Officier, Optum Rx Moderator: Ian Spatz, National Advisor, Manatt Health
11:15 am – 12:00 pm Psychedelic Medicines: Navigating the regulatory landscape to ensure patient access Kabir Nath, Chief Executive Officer, Compass Pathways Ross Hoffman, MD, Chief Medical Officer, Centene Pharmacy Services Moderator: Ian Spatz, National Advisor, Manatt Health
| |
| 12:15 pm - 2:00 pm | Member Company Lunch Receptions Frank Lloyd Wright Ballroom
Attendees flow in and out of the concurrent Member Company Receptions while the members serve as hosts. Only drug manufacturer representatives will be permitted into these lunch receptions. *General Lunch will be served in Frank Lloyd Wright Ballroom Salon F | |
| 6:00 pm - 8:00 pm | Cocktail and Dinner Reception with Live Music Spire Lawn |
| 7:00 am - 4:00 pm | Registration Open McArthur Ballroom Foyer | |
| 7:00 am - 5:30 pm | Private Meeting Rooms Open | |
| 7:30 am - 9:00 am | General Networking Breakfast McArthur Patio | |
| 9:00 am - 12:00 pm | GENERAL SESSIONS McArthur Ballroom
9:00 am – 9:30 am Understanding Congressional PBM Regulatory Proposals Kristin Bass, Chief Policy & External Affairs Officer, PCMA Moderator: Ian Spatz, National Advisor, Manatt Health
9:30 am – 10:00 am PCMA Board Leadership Keynote Session Mostafa Kamal, President & Chief Executive Officer, Prime Therapeutics Paul Marchetti, President, CarelonRx Moderator: Ian Spatz, National Advisor, Manatt Health
10:00 am – 10: 45 am IRA Drug Pricing Provisions: Long-term market impact Derek Asay, Senior Vice President, Government Strategy & Federal Accounts, Eli Lilly and Company Anna Kaltenboeck, Principal and Head of Prescription Drug Reimbursement Practice, ATI Advisory Jamey Millar, Senior Vice President, Industry Relations, Optum Rx Moderator: Ian Spatz, National Advisor, Manatt Health
10:45 am – 11:15 am The Rapid Acceleration of Medical Benefit Drug Management Steve Cutts, PharmD, Senior Vice President and Market General Manager, Specialty, Magellan Rx Moderator: Ian Spatz, National Advisor, Manatt Health
11:15 am – 12:00 pm Clinical Effectiveness and Market Feasibility of New Drug Approvals Jeremy Fredell, Vice President, Pharma Strategy & Contracting, Express Scripts Jason Zilocchi, Market Access Strategy Lead, Advantage Point Solutions Moderator: Ian Spatz, National Advisor, Manatt Health
| |
| 12:15 pm - 2:00 pm | General Networking Lunch Grand Ballroom | |
| 8:00 pm - 10:00 pm | Cocktail and Dessert Reception Spire Lawn
|
